Corgi IP Licensing & Royalties ETF

PTNT · ETF

$24.15−$0.1209 (−0.50%)TodayMarket closed ·
No price history for this range.

Latest news

  • Press releasePRNewswire

    Palatin Presents Data at ObesityWeek® 2025 Highlighting Promise of Melanocortin-Based Therapies for Obesity

  • Press releasePRNewswire

    Palatin Technologies Announces Pricing of Upsized $15.8 Million Public Offering

  • Press releasePRNewswire

    Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim

  • Press releasePRNewswire

    Palatin Announces 1-for-50 Reverse Stock Split

  • Press releasePRNewswire

    Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity

  • Press releasePRNewswire

    Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update

  • Press releasePRNewswire

    Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025

  • Press releasePRNewswire

    Palatin Technologies Announces Closing of Reduced Public Offering

  • Press releasePRNewswire

    Palatin Presents Breakthrough Symptom Resolution Data from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease at ARVO 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.